Last reviewed · How we verify
NCT05922150
Effect of LLLT and Ozone to Reduce Complications After Extraction of Impacted Lower Molar
NA trial testing low level laser therapy in Complications of Extraction of Impacted Teeth in 60 participants. Completed in 9 November 2022.
1 October 2022
Quick facts
| Lead sponsor | University of Baghdad |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 9 March 2022 |
| Primary completion | 1 October 2022 |
| Estimated completion | 9 November 2022 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- low level laser therapy — full drug profile →
- ozone gel
Conditions studied
- Complications of Extraction of Impacted Teeth — all drugs for Complications of Extraction of Impacted Teeth →
Sponsor
University of Baghdad
Who can join
Adults 18 to 38, any sex, with Complications of Extraction of Impacted Teeth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many factors cause third molars to stay impacted in the jaws, hence the extraction of impacted wisdom teeth occurs often in dental clinics. Pain, trismus, and edema are typical postoperative complications following third molar surgery. Various strategies have been developed to prevent or reduce these postoperative complications, Among these is the use of Low-Level Laser Therapy (LLLT), which demonstrates numerous benefits in lowering pain, trismus, and edema by managing inflammation. The precise biological mechanism of action remains unknown. There seems to be evidence that it may have neuro-pharmacological impacts on the production, metabolism, and release of a number of biological compounds, the other option is use of ozone which has antimicrobial effectiveness (viricidal, bactericidal, and fungicidal). Additional well-known advantages include immunological modulatory and stimulating actions, including anti-inflammatory, biosynthetic, anti-hypoxic, and bioenergetic characteristics. Ozone can interact with blood components in the right amounts to positively impact oxygen metabolism and cell energy while also triggering antioxidant defense mechanisms
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05922150
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of low level laser therapy
Trials testing the same drug.
- NCT07171788 — Effects of Low Level Laser Therapy on Wrist Flexors Spasticity and Hand Functions in Patients With Stroke · NA · not yet recruiting
- NCT06762197 — Radial Shockwave Versus Low Level Laser Therapy in Patients With Chronic Piriformis Muscle Syndrome · NA · not yet recruiting
- NCT06164626 — Evaluation of Bone Preservation After Molar Extraction Using Photobiomodulation Combined With Biomaterial Grafting · Phase 1 · unknown
- NCT04230096 — Effects Of Low Level Laser Therapy On Tooth Movement,Treatment Related Complications Of Gingivitis,Periodontitis And Pai · NA · completed
- NCT05867888 — Shock Wave Therapy Versus Low Level Laser Therapy in Patients With Plantar Fasciitis · NA · completed
Other University of Baghdad trials
Trials by the same sponsor.
- NCT07417839 — (Effect of Toy Nebulizer Versus Distraction Cards on Children's Fear and Parental Satisfaction During Nebulization Thera · NA · not yet recruiting
- NCT07456657 — Effect of Lavender Aromatherapy Massage on Pain and Wrist Mobility in Rheumatoid Arthritis · NA · not yet recruiting
- NCT07460089 — Premature Infant Oral Motor Intervention vs. Pacifier for Oral Feeding Transition in Preterm Infants · NA · not yet recruiting
- NCT07350343 — The Predictability of Directly Printed Versus Thermoformed Clear Aligners · NA · enrolling by invitation
- NCT07362160 — Clear Orthodontic Expander Versus Hyrax · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05922150 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Baghdad
- Last refreshed: 28 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05922150.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing